Class II · Moderate risk
ORPHENADRINE CITRATE ER Tablet
Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002965, EXP: 6/10/2014.
National Drug Code
Is NDC 43386-0480-24 recalled?
Orphenadrine Citrate · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (43386-480-24)
Yes — this exact package was recalled
1 FDA recall names the code 43386-0480-24 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Orphenadrine Citrate
- Strength
- ORPHENADRINE CITRATE 100 mg/1
- Form
- Tablet, Extended Release · Oral
- Labeler
- Lupin Pharmaceuticals, Inc.
- Type
- Human Prescription Drug
- Product code
- 43386-0480
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 43386-0069 Fluocinolone Acetonide 3
- 43386-0060 GaviLyte - C TM 2
- 43386-0450 Nitrofurantoin 2
- 43386-0541 Morphine Sulfate 2
- 43386-0038 Voriconazole 1
- 43386-0050 Gavilyte-N 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.